{
    "relation": [
        [
            "type",
            "FR Doc.",
            "RIN",
            "Docket No."
        ],
        [
            "regulations.gov",
            "2014-11635",
            "",
            "FDA-2014-N-0440"
        ]
    ],
    "pageTitle": "21 CFR Part 866, Subpart B - Diagnostic Devices | US Law | LII / Legal Information Institute",
    "title": "",
    "url": "https://www.law.cornell.edu/cfr/text/21/part-866/subpart-B",
    "hasHeader": true,
    "headerPosition": "FIRST_ROW",
    "tableType": "RELATION",
    "tableNum": 25,
    "s3Link": "common-crawl/crawl-data/CC-MAIN-2015-32/segments/1438042988930.94/warc/CC-MAIN-20150728002308-00133-ip-10-236-191-2.ec2.internal.warc.gz",
    "recordEndOffset": 928280527,
    "recordOffset": 928266742,
    "tableOrientation": "HORIZONTAL",
    "TableContextTimeStampBeforeTable": "{1137=Title 21 published on 2014-04-01.}",
    "TableContextTimeStampAfterTable": "{28619=Title 21 published on 2014-04-01}",
    "lastModified": "Mon, 01 Jun 2015 05:44:47 GMT",
    "textBeforeTable": "Additional Documents GPO FDSys XML | Text 80 FR 30153 - Medical Devices; Immunology and Microbiology Devices; Classification of Multiplex Nucleic Acid Assay for Identification of Microorganisms and Resistance Markers From Positive Blood Cultures 2015-05-27; vol. 80 # 101 - Wednesday, May 27, 2015 For a complete list of all Rules, Proposed Rules, and Notices view the Rulemaking tab. The following are only the Rules published in the Federal Register after the published date of Title 21. Title 21 published on 2014-04-01. \u00a7 866.1700 \u2014 Culture medium for antimicrobial susceptibility tests. \u00a7 866.1645 \u2014 Fully automated short-term incubation cycle antimicrobial susceptibility system. \u00a7 866.1640 \u2014 Antimicrobial susceptibility test powder. \u00a7 866.1620 \u2014 Antimicrobial susceptibility test disc. next prev |",
    "textAfterTable": "DEPARTMENT OF HEALTH AND HUMAN SERVICES, Food and Drug Administration Final order. This order is effective May 27, 2015. The classification was applicable June 26, 2012. 21 CFR Part 866 Summary The Food and Drug Administration (FDA) is classifying multiplex nucleic acid assay for identification of microorganisms and resistance markers from positive blood cultures into class II (special controls). The special controls that will apply to this device are identified in this order and will be part of the codified language for the multiplex nucleic acid assay for identification of microorganisms and resistance markers from positive blood cultures. The Agency is classifying the device into class II (special controls) in order to provide a reasonable assurance of safety and effectiveness of the device. 2014-10-22; vol. 79 # 204 - Wednesday, October 22, 2014 79 FR 63034 - Medical Devices; Immunology and Microbiology Devices; Classification of Nucleic Acid-Based Devices for the Detection of Mycobacterium Tuberculosis Complex and the Genetic Mutations Associated With Antibiotic Resistance GPO FDSys XML |",
    "hasKeyColumn": false,
    "keyColumnIndex": -1,
    "headerRowIndex": 0
}